# ACOART SCB BIF: Treatment of Coronary Bifurcation Lesion by Sirolimus Coated Balloon vs Paclitaxel Coated Balloon

> **NCT04899583** · NA · UNKNOWN · sponsor: **Acotec Scientific Co., Ltd** · enrollment: 230 (estimated)

## Conditions studied

- Coronary Bifurcation Lesions

## Interventions

- **DEVICE:** Sirolimus Coated Balloon Catheter
- **DEVICE:** a Paclitaxel Coated Balloon Catheter

## Key facts

- **NCT ID:** NCT04899583
- **Lead sponsor:** Acotec Scientific Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-10
- **Primary completion:** 2024-11-01
- **Final completion:** 2025-11-01
- **Target enrollment:** 230 (ESTIMATED)
- **Last updated:** 2023-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04899583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04899583, "ACOART SCB BIF: Treatment of Coronary Bifurcation Lesion by Sirolimus Coated Balloon vs Paclitaxel Coated Balloon". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04899583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*